Table 2.
Variable | HCC versus CH (n = 107) versus (n = 159) |
HCC versus LC (n = 107) versus (n = 99) |
HCC versus CH + LC (n = 107) versus (n = 258) |
||||||
---|---|---|---|---|---|---|---|---|---|
OR | SE | p | OR | SE | p | OR | SE | P | |
Gender (Male/female) | 19.288 | 0.995 | 0.003 | 5.612 | 0.844 | 0.041 | 14.364 | 0.906 | 0.003 |
Age (years) | 1.137 | 0.032 | < 0.0001 | 1.061 | 0.030 | 0.047 | 1.100 | 0.024 | < 0.0001 |
HBV DNA (IU/mL, log) | 0.656 | 0.234 | 0.072 | 0.619 | 0.210 | 0.022 | 0.672 | 0.163 | 0.015 |
ALT (IU/L) | 0.996 | 0.004 | 0.243 | 0.999 | 0.005 | 0.767 | 0.997 | 0.003 | 0.303 |
AST (IU/L) | 1.003 | 0.004 | 0.421 | 1.002 | 0.003 | 0.570 | 1.002 | 0.002 | 0.388 |
TBIL (μmol/L) | 0.997 | 0.003 | 0.330 | 1.002 | 0.005 | 0.687 | 1.000 | 0.003 | 0.979 |
Albumin (g/L) | 0.995 | 0.061 | 0.930 | 0.909 | 0.043 | 0.026 | 0.942 | 0.038 | 0.120 |
PTX3 (ng/mL) | 1.639 | 0.097 | < 0.0001 | 1.671 | 0.104 | < 0.0001 | 1.617 | 0.075 | < 0.0001 |
AFP (ng/mL) | 1.001 | 0.0002 | 0.014 | 1.003 | 0.002 | 0.193 | 1.001 | 0.0002 | 0.002 |
HBV hepatitis B virus, HCC hepatocellular carcinoma, ALT alanine aminotransferase, AST aspartate aminotransferase, TBIL total bilirubin, PTX3 pentraxin 3, AFP α-fetoprotein, CH chronic hepatitis, LC liver cirrhosis.